Insulin

Insulin Device Maker Embecta Weighs Sale After 70% Share Decline Following Becton Dickinson Spin-Off

House Passes Bill To Cap Out-of-Pocket Insulin Costs To No More Than $35/Month

Novo Nordisk Settles Insulin Pricing Lawsuit For $100M

House Passes Bill To Cap Out-of-Pocket Insulin Costs To No More Than $35/Month

Novo Nordisk Settles Insulin Pricing Lawsuit For $100M

House Committee Questions Eli Lilly, Sanofi, Novo Nordisk On 'Unacceptably High' Insulin Prices

FDA Clears Use Of Eli Lilly's Insulin With Insulet's Infusion Pumps

House Committee Questions Eli Lilly, Sanofi, Novo Nordisk On 'Unacceptably High' Insulin Prices

FDA Clears Use Of Eli Lilly's Insulin With Insulet's Infusion Pumps

Viatris Stock Gains After FDA Approves Viatris-Biocon Biologics' Insulin Glargine Biosimilar Injection

Eli Lilly To Look For Ways To Cut Insulin Costs After Walmart Debut: CNBC

Insulin Recent News

Walmart, Novo Nordisk Unveil Own Low-Cost Brand Insulin

Sanofi's Soliqua Shows Improved Blood Sugar Control Without Weigh Gain Against Premixed Insulin

Eli Lilly CEO Hits Back At Elizabeth Warren, Blames PBMs, Insurance For Blocking Affordable Insulin

Tandem Diabetes Says Death Of Patient Wasn't Due To Insulin Pump Malfunction

The 4 Tailwinds Driving Raymond James' Insulet Bull Case

New Label For Afrezza Could Turn Things Around At MannKind

New Report Questions Insulet Management's 'Baseless' Claims: 'Investors Being Led To The Slaughter'

Analyst: MannKind Afrezza Estimates Are Being Changed 'Based On Physician Feedback'

Global Diabetes Market Trends & Future Forecast